Sign In
to Vote &
Create Storyboards.
 
By combining standard desensitization of up to five food allergies with antibody-based medication omalizumab, it may be possible to treat multiple food allergies in a shorter timeframe. This is according to a Phase 1 trial, with 25 patients, published in open access journal Allergy, Asthma & Clinical Immunology. Food allergies affect up to 8% of children in the US, and 30% of those affected have more than one allergy. It has been estimated that food allergies cost US$25 billion each year, with a...
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard